Neumora Therapeutics, Inc. (NMRA)
2.09
+0.02
(+0.72%)
USD |
NASDAQ |
Dec 10, 16:00
2.08
-0.01
(-0.48%)
After-Hours: 07:25
Neumora Therapeutics Total Assets (Quarterly): 177.83M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| TransMedics Group, Inc. | 946.03M |
| CAMP4 Therapeutics Corp. | 86.40M |
| Puma Biotechnology, Inc. | 202.86M |
| Coherus Oncology, Inc. | 516.52M |
| Ventyx Biosciences, Inc. | 211.46M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 45.67M |
| Shareholders Equity (Quarterly) | 132.16M |
| Debt to Equity Ratio | 0.152 |
| Current Ratio | 6.852 |
| Net Debt Paydown Yield | -1.12% |